| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/24/2008 | EP2006299A1 Identification of new isoforms of the MHC-class I specific receptor CD160 and uses thereof |
| 12/24/2008 | EP2006298A2 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof |
| 12/24/2008 | EP2006296A1 Crustacean-derived protein having antifreeze activity |
| 12/24/2008 | EP2006295A2 Protein having ice nucleating activity |
| 12/24/2008 | EP2006294A1 Tumour-associated peptides that bind to MHC molecules |
| 12/24/2008 | EP2005996A2 Immunotherapeutic combination for the treatment of tumors |
| 12/24/2008 | EP2005966A1 Survivin-derived peptides and use thereof |
| 12/24/2008 | EP2005174A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory |
| 12/24/2008 | EP2005171A2 Inflammation-inhibitory serum factors and uses thereof |
| 12/24/2008 | EP2004844A2 Coadministration of alpha-fetoprotein and a disease modifying anti-rheumatic drug for treating inflammatory arthritic disease |
| 12/24/2008 | EP2004817A2 Polypeptides having endoglucanase activity and polynucleotides encoding same |
| 12/24/2008 | EP2004814A2 A group of novel enantioselective microbial nitrile hydratases with broad substrate specificity |
| 12/24/2008 | EP2004694A2 Methods for preventing and treating amyloidogenic diseases |
| 12/24/2008 | EP2004683A2 Pc5 as a factor ix propeptide processing enzyme |
| 12/24/2008 | EP2004682A2 Tetramerizing polypeptides and methods of use |
| 12/24/2008 | EP2004681A1 Polypeptide antagonist |
| 12/24/2008 | EP2004680A2 N-terminal vdac variants and uses thereof |
| 12/24/2008 | EP2004679A2 Maize genes for controlling plant growth and organ size and their use in improving crop plants |
| 12/24/2008 | EP2004678A1 Modulation of glutamine synthetase activity |
| 12/24/2008 | EP2004677A2 Chimeric viral envelopes |
| 12/24/2008 | EP2004676A2 Peptide sequences and compositions |
| 12/24/2008 | EP2004674A1 Antimicrobial protein |
| 12/24/2008 | EP2004666A2 Ras mutation and compositions and methods related thereto |
| 12/24/2008 | EP2004226A1 Storage of influenza vaccines without refrigeration |
| 12/24/2008 | EP2004217A1 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |
| 12/24/2008 | EP2004213A1 Glp-1 peptide agonists |
| 12/24/2008 | EP2004210A2 Antiangiogenic peptide and therapeutic uses thereof |
| 12/24/2008 | EP2004209A2 Composition and method for stabilizing corneal tissue after refractive surgery |
| 12/24/2008 | EP2004202A1 Use of a growth-stimulating protein |
| 12/24/2008 | EP1871802A4 Recombinant e-selectin made in insect cells |
| 12/24/2008 | EP1572720A4 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides |
| 12/24/2008 | EP1564557B1 Method for cancer detection, progression analysis and malign tumour prognosis based on the study of metabolic markers of the cell |
| 12/24/2008 | EP1519953B1 Avian cytokines, such il-12, comprising a p40 and/or p35 subunit(s) |
| 12/24/2008 | EP1513945A4 Method for universal enzymatic production of bioactive peptides |
| 12/24/2008 | EP1328649B1 Plant cell death system |
| 12/24/2008 | EP1218511B1 Antimicrobial compositions |
| 12/24/2008 | EP1181555B1 Cancer treatment with endothelin receptor antagonists |
| 12/24/2008 | EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response |
| 12/24/2008 | EP1097212B1 Anthrax vaccine |
| 12/24/2008 | EP1012174B1 Nik proteins, nucleic acids and methods |
| 12/24/2008 | EP1003773B1 Ctl epitopes of epstein-barr virus |
| 12/24/2008 | CN101330928A Immunostimulatory combination for the prophylactics and treatment of hepatitis c |
| 12/24/2008 | CN101330927A Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant |
| 12/24/2008 | CN101328484A Delta-endotoxin genes and methods for their use |
| 12/24/2008 | CN101328483A Chrysalid pteromalid antibiotic protein Pp-Ap1 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328482A Chrysalid pteromalid antibiotic protein Pp-AP2 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328481A Chrysalid pteromalid antibiotic protein Pp-AP3 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328480A Chrysalid pteromalid antibiotic protein Pp-AP4 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328479A Chrysalid pteromalid antibiotic protein Pp-AP5 and encoding nucleic acid sequence thereof |
| 12/24/2008 | CN101328478A Protein having antiplatelet embolism activity, production method and use thereof |
| 12/24/2008 | CN101328221A Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
| 12/24/2008 | CN101328220A Preparation and use of galactosylated human serum albumin fused interferon |
| 12/24/2008 | CN101328218A Preparation of diisooctyl phthalate artificial antigen |
| 12/24/2008 | CN101328217A Preparation of phthalandione diethyl artificial antigen |
| 12/24/2008 | CN101328216A Synthetic method of perfluorooctanoic acid medicament universal artificial antigen |
| 12/24/2008 | CN101328215A Synthetic method of bisphenol A medicament universal artificial antigen |
| 12/24/2008 | CN101328214A Liver disease blood serum specific protein and use thereof |
| 12/24/2008 | CN101328213A G-CSF conjugates |
| 12/24/2008 | CN101328212A Cultivating method for improving cotton fiber quality |
| 12/24/2008 | CN101328211A Two leptospira outer membrane proteins of vaccine candidates |
| 12/24/2008 | CN101328210A HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 12/24/2008 | CN101328209A HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 12/24/2008 | CN101328208A HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV |
| 12/24/2008 | CN101328204A Preparation of dioctyl phthalate artificial antigen |
| 12/24/2008 | CN100445394C Method for controlling cleavage by ompT protease |
| 12/24/2008 | CN100445371C Production process of human-alpha phylaxin-1 protein with colibacillus |
| 12/24/2008 | CN100445299C Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene |
| 12/24/2008 | CN100445298C Plant resistance relevant protein and its coding gene and application |
| 12/24/2008 | CN100444838C Use of inhibitors for treatment of disorders related to RTK hyperfunction |
| 12/24/2008 | CA2727391A1 Azapeptides as cd36 binding compounds |
| 12/24/2008 | CA2703533A1 Polynucleotides and methods for making plants resistant to fungal pathogens |
| 12/24/2008 | CA2696615A1 Oligosaccharide chain added glp-1 peptide |
| 12/24/2008 | CA2691386A1 Biological active proteins having increased in vivo and/or in vitro stability |
| 12/24/2008 | CA2691243A1 Thrombin inhibitor |
| 12/24/2008 | CA2691110A1 Modified human factor vii/viia and pharmaceutical composition containing same |
| 12/24/2008 | CA2691091A1 Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
| 12/24/2008 | CA2691089A1 Use of tlr agonists and/or type 1 interferons to alleviate toxicity of tnf-r agonist therapeutic regimens |
| 12/24/2008 | CA2691033A1 Capsid proteins and uses therefore |
| 12/24/2008 | CA2690783A1 Secondary wall forming genes from maize and uses thereof |
| 12/24/2008 | CA2690668A1 Vaccines containing canine parvovirus genetic variants |
| 12/24/2008 | CA2690658A1 Synthetic repetitive proteins, their production and use thereof |
| 12/24/2008 | CA2690627A1 Microorganisms for imaging and/or treatment of tumors |
| 12/24/2008 | CA2690402A1 Copolymer assay |
| 12/24/2008 | CA2690376A1 Apoa-1 peptide mimetics |
| 12/24/2008 | CA2690271A1 Chlamydia antigens |
| 12/24/2008 | CA2690056A1 Rage fusion proteins |
| 12/24/2008 | CA2689588A1 Promoterless cassettes for expression of alphavirus structural proteins |
| 12/23/2008 | US7468477 Plants and seeds of hybrid corn variety CH824610 |
| 12/23/2008 | US7468472 Polynucleotides encoding proteins involved in plant metabolism |
| 12/23/2008 | US7468430 Transposase and method of gene modification |
| 12/23/2008 | US7468427 Antibodies to PRO1275 polypeptide |
| 12/23/2008 | US7468425 p40 protein acts as an oncogene |
| 12/23/2008 | US7468424 Antibody that binds to the protein; given amino acid sequence |
| 12/23/2008 | US7468423 Homogeneous preparations of IL-28 and IL-29 |
| 12/23/2008 | US7468422 Mechanosensitive mammalian potassium channel activatable by polyunsaturated fatty acids |
| 12/23/2008 | US7468420 Process for purifying glycopeptide phosphonate derivatives |
| 12/23/2008 | US7468367 depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis/disorder; depressive neurosis/disorder, anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; sex disorder, sexual disorder; schizophrenia; manic depression; |
| 12/23/2008 | US7468353 Treating idiopathic pulmonary fibrosis, hypersensitive pneumonia or diffused panbronchiolitis by administering a peptide or a polypeptide with the same biological activity as Vasoactive Intestinal Peptide or Pituitary Adenylate Cyclase-Activating Polypeptide: Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu |
| 12/23/2008 | US7468352 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 12/23/2008 | US7468351 Erythropoietin solution formulation |